-The Hindu   Obesity among children due to rampant consumption of junk food has reached epidemic proportions. With India already in the grip of this dangerous global trend, the government needs to remove its blinkers on the processed food industry One of the first declarations of the newly elected government in June was a proposal to ban unhealthy or junk food (defined as food high on fat, sugar and salt) in school...

-The Hindu Business Line     A set of technologies that deals with production and marketing constraints can work wonders Indian agriculture faces herculean challenges today; yet, the near- and the medium-term outlook on agriculture and agri-businesses seem bright. Growing urbanisation and changing food habits, malnutrition plus declining areas under foodgrain pose a big threat to food security. Agriculture and food production are strongly influenced by international trade, credit availability, development co-operation, climate change and environmental...

-The Times of India   NEW DELHI: The World Health Organisation's (WHO) work of setting up norms and standards for production of medicines seems to be flawed by a fundamental conflict of interest. At the heart of its standard setting work is an entity the International Conference on Harmonization (ICH) in which majority of the WHO member countries have no voting rights and which is dominated by pharmaceutical industry groups. This glaring...

-Live Mint   Strong political commitment is needed to build a system of universal health coverage and better regulations   Life expectancy in India has more than doubled since independence, to 65 years, from just 32 in 1950. The infant mortality rate has been cut by two-thirds since 1971. Smallpox and guinea worm have been eradicated, the spread of HIV/AIDS has been contained, and the World Health Organization has declared India polio-free.   Yet for all...

-The Hindu Differences over intellectual property rights (IPRs) have emerged as a strong undercurrent in India's economic relations with the U.S. The attempt by the influential pharmaceutical lobby to stymie India's efforts to ensure the supply of medicines at affordable rates without violating existing treaty commitments, requires a principled response from New Delhi. At the core of the issue is what Columbia University Professor Arvind Panagariya calls "the hijacking of...